









|
| �@ŠÖ“Œ˜A�‡ŽY‰È•w�l‰ÈŠw‰ï‰ïŽ� ƒIƒ“ƒ‰ƒCƒ“ƒWƒƒ�[ƒiƒ‹ |
<< Šw‰ïŽ�‚Ö–ß‚é
<< ‘O‚̃y�[ƒW‚Ö–ß‚é
‘æ93‰ñŠw�p�W‰ï�i•½�¬9”N6ŒŽ22“ú�j
�yˆê”ʉ‰‘è�z
Žq‹{èò•”adenoma malignum�iminimal deviation adenocarcinoma�j‚Ì2—á
•½“ˆ�@‘×”V, �¬—Ñ�@�_, ‘åˆä�@�‹ˆê, Šâ�é�@�F�s, �¬—Ñ�@—²•v, Ž›”ö�@�r•F
•l�¼ˆã‰È‘åŠwŽY•w�l‰È
“ú–{ŽY‰È•w�l‰ÈŠw‰ïŠÖ“Œ˜A�‡’n•û•”‰ï‰ï•ñ, 34(2)
194-194, 1997
|